Infectious Diseases

502 questions

Question 41Question →

A variety of patients present to the clinic and emergency department seeking care after high-risk infectious exposures. Match each clinical exposure scenario to the most appropriate post-exposure prophylaxis or preventive intervention.

Click a left item, then click its matching right item

Items

A 26-year-old healthcare worker with zero documented lifetime doses of any hepatitis vaccines sustains a hollow-bore needlestick injury from a patient known to be HBsAg-positive and HBeAg-positive.
A 28-year-old man presents to the clinic 12 hours after condomless receptive anal intercourse with a partner known to have untreated HIV infection.
A 20-year-old college student whose dormitory roommate was admitted to the intensive care unit yesterday for confirmed Neisseria meningitidis sepsis.
A 42-year-old agricultural worker who immigrated recently with an unknown immunization history presents with a deep, soil-contaminated puncture wound from a rusty farming tool.

Matches

Show answer & explanation

Answer

Hepatitis B exposure maps to HBIG and vaccine. HIV exposure maps to 3-drug ART for 28 days. Meningococcal contact maps to ciprofloxacin, rifampin, or ceftriaxone. Dirty wound with unknown vaccination maps to Tetanus toxoid and TIG.
Each correct pairing directly reflects current CDC and infectious disease guidelines for post-exposure prophylaxis. The needlestick with no HBV immunity requires HBIG + Vaccine. The high-risk HIV exposure requires full 3-drug ART. The close meningococcal contact requires nasopharyngeal eradication with ciprofloxacin, rifampin, or ceftriaxone. The dirty wound in a patient without documented tetanus primary series requires Tdap + TIG.

Step-by-Step Solution

1
Analyze the nature of the infectious exposure and the patient's baseline immune/vaccination status.
Identified four distinct scenarios: unvaccinated Hepatitis B blood exposure, high-risk HIV sexual exposure, close respiratory contact with meningococcus, and a severe wound with unknown tetanus immunity.
Post-exposure prophylaxis depends heavily on both the exact pathogen and the host's prior immunologic memory.
2
Determine the mechanism of protection required for each pathogen.
Hepatitis B and tetanus in naive hosts require immediate antibody neutralization (immune globulin) plus long-term memory (vaccine). Meningococcus requires bacterial eradication (antibiotics). HIV requires viral replication inhibition (antiretrovirals).
Different pathogens have different incubation periods and pathogenesis, dictating whether pharmacological, active immunologic, or passive immunologic interventions are effective.
3
Match the clinical scenario to the guideline-concordant preventive regimen.
Successfully paired each scenario with its respective evidence-based prophylaxis.
Ensures adherence to current infectious disease and public health guidelines.

Key Concept

Selection of targeted post-exposure prophylaxis based on pathogen type, exposure severity, and host immune status.
Question 42Question →

Match each clinical presentation in a patient with advanced HIV infection to the most likely central nervous system etiology.

Click a left item, then click its matching right item

Items

A 35-year-old patient with a CD4 count of 80 cells/mm³ presents with fever, seizures, and hemiparesis. Brain MRI reveals multiple ring-enhancing lesions predominantly in the basal ganglia and cerebral cortex.
A 42-year-old patient with a CD4 count of 30 cells/mm³ presents with focal neurologic deficits. Brain MRI demonstrates a solitary, large, weakly ring-enhancing periventricular lesion. Cerebrospinal fluid PCR is positive for Epstein-Barr virus.
A 39-year-old patient with a CD4 count of 45 cells/mm³ develops progressive aphasia, ataxia, and hemiparesis without fever. Brain MRI demonstrates asymmetric, non-enhancing white matter lesions lacking mass effect.
A 45-year-old patient with a CD4 count of 90 cells/mm³ presents with a 2-week history of severe headache, nausea, and photophobia. Lumbar puncture reveals an opening pressure of 320 mm H₂O and encapsulated budding yeast.
A 50-year-old patient with prolonged, untreated HIV infection exhibits progressive memory loss, apathy, and psychomotor slowing over 6 months. Brain MRI shows diffuse cortical atrophy and symmetric periventricular white matter pallor.

Matches

Show answer & explanation

Answer

The correct pairings match each clinical vignette to its corresponding HIV-associated central nervous system complication based on CD4 count thresholds, distinct neuroimaging characteristics, and cerebrospinal fluid findings.
Each diagnosis represents a distinct opportunistic condition in advanced HIV, distinguishable by unique neuroimaging patterns (enhancing vs. non-enhancing, solitary vs. multiple, mass effect vs. no mass effect), focal versus global neurologic symptoms, and specific cerebrospinal fluid analysis findings.

Step-by-Step Solution

1
Analyze the first clinical vignette focusing on CD4 count (< 100 cells/mm³), symptoms (seizures, focal deficits), and MRI findings (multiple ring-enhancing lesions in basal ganglia).
Identified as Toxoplasma gondii encephalitis.
This is the most common cause of focal brain lesions in patients with AIDS, characterized classically by multiple enhancing lesions in the deep white matter and basal ganglia.
2
Analyze the second vignette focusing on the solitary, large periventricular mass and positive CSF Epstein-Barr virus PCR.
Identified as Primary central nervous system lymphoma.
Primary CNS lymphoma in HIV is an AIDS-defining malignancy heavily associated with EBV, presenting typically as a solitary, weakly enhancing periventricular mass.
3
Evaluate the third vignette noting the lack of mass effect, non-enhancing asymmetric white matter lesions, and subacute focal deficits.
Identified as Progressive multifocal leukoencephalopathy.
PML is a demyelinating disease caused by JC virus reactivation, classically appearing on MRI as patchy, non-enhancing white matter lesions without edema or mass effect.
4
Review the fourth vignette recognizing the high CSF opening pressure and presence of encapsulated budding yeast.
Identified as Cryptococcal meningitis.
Cryptococcal neoformans characteristically causes severe meningoencephalitis with highly elevated opening pressures; encapsulated budding yeast is pathognomonic on India ink or histopathology.
5
Assess the final vignette identifying the gradual cognitive decline combined with symmetric atrophy and white matter changes.
Identified as HIV-associated neurocognitive disorder.
HAND (including HIV dementia) presents with progressive cognitive and motor decline; MRI reflects generalized brain volume loss and diffuse, symmetric white matter signal abnormalities without focal lesions.

Key Concept

Differential diagnosis of central nervous system lesions and infections in patients with advanced HIV, utilizing neuroimaging, CD4 count, and CSF analysis.
Estimated Time:2m 0s
Question 43Question →

Match each clinical presentation of a zoonotic or vector-borne infectious disease with the most appropriate targeted antimicrobial therapy.

Click a left item, then click its matching right item

Items

A 30-year-old man from the Northeast United States presents with fever and dark urine; laboratory testing reveals hemolytic anemia, thrombocytopenia, and intraerythrocytic tetrads on a peripheral blood smear.
A 25-year-old woman presents with a tender, enlarged axillary lymph node; she reports adopting a kitten a few weeks ago and has a healing scratch on her ipsilateral hand.
A 35-year-old man recently returned from rural South America presents with fever and unilateral painless periorbital edema; blood microscopy reveals motile trypomastigotes.
A 40-year-old man presents with an ulcerated skin lesion with a dark eschar on his hand and painful regional lymphadenopathy; he recently hunted and skinned a wild rabbit.
A 42-year-old farmer presents with high fever, severe headache, and a nonproductive cough after assisting with sheep parturition; testing shows elevated transaminases and interstitial pneumonia.

Matches

Show answer & explanation

Answer

The correct matches align specific zoonotic and vector-borne clinical syndromes with their definitive antimicrobial therapies: Babesiosis is treated with atovaquone and azithromycin; cat scratch disease with azithromycin; Chagas disease with benznidazole; tularemia with streptomycin; and Q fever with doxycycline.
Each pathogen requires a specific class of antimicrobial based on its unique biology: Babesia (protozoan) requires atovaquone/azithromycin; Bartonella (fastidious bacteria) responds to azithromycin; Trypanosoma (parasite) requires benznidazole; Francisella (Gram-negative coccobacillus) is best treated with aminoglycosides; and Coxiella (intracellular bacteria) requires tetracyclines.

Step-by-Step Solution

1
Identify the etiology for each distinct clinical vignette based on exposure history and physical or laboratory findings.
The vignettes describe Babesiosis, cat scratch disease, Chagas disease, tularemia, and Q fever, respectively.
Accurate pathogen identification is the prerequisite for selecting targeted antimicrobial therapy.
2
Determine the therapy for Babesiosis (hemolytic anemia, intraerythrocytic tetrads).
Match with atovaquone and azithromycin.
This combination effectively targets the intraerythrocytic protozoa while minimizing toxicity.
3
Determine the therapy for cat scratch disease (kitten exposure, regional lymphadenitis).
Match with azithromycin.
A short course of azithromycin accelerates the resolution of Bartonella henselae lymphadenopathy.
4
Determine the therapy for acute Chagas disease (South American travel, Romaña sign).
Match with benznidazole.
Benznidazole (or nifurtimox) is the required therapy for acute Trypanosoma cruzi infection.
5
Determine the therapy for tularemia (rabbit exposure, ulceroglandular disease).
Match with streptomycin.
Aminoglycosides are the gold standard for severe or ulceroglandular Francisella tularensis infection.
6
Determine the therapy for acute Q fever (livestock exposure, atypical pneumonia/hepatitis).
Match with doxycycline.
Doxycycline effectively clears the intracellular pathogen Coxiella burnetii.

Key Concept

Targeted antimicrobial therapy for zoonotic and vector-borne infectious diseases must be selected based on distinct epidemiological exposures and classic clinical manifestations.
Estimated Time:1m 30s
Question 44Question →

Match each clinical presentation of pneumonia or febrile respiratory illness to its most likely causative pathogen based on the provided epidemiological clues and distinct clinical findings.

Click a left item, then click its matching right item

Items

An older male patient with chronic alcohol dependence is evaluated for fever, thick hemoptysis, and radiographic evidence of a right upper lobe cavitary lesion.
A maintenance technician working on a commercial cooling tower develops acute respiratory distress accompanied by loose stools, confusion, and laboratory evidence of severe hyponatremia.
A university dormitory resident seeks care for an unrelenting nonproductive cough, low-grade temperature, and a newly developed rash characterized by target-like macules on both arms.
An exotic bird handler is admitted with a severe headache, photophobia, dry cough, and widespread patchy infiltrates on a chest radiograph.
A livestock farm employee is investigated for a prolonged febrile illness, profound fatigue, elevated liver transaminases, and a normal white blood cell count, notably lacking any cutaneous eruptions.

Matches

Show answer & explanation

Answer

The scenarios match to: Alcohol dependence -> Klebsiella pneumoniae; Cooling tower -> Legionella pneumophila; Dormitory resident with targetoid rash -> Mycoplasma pneumoniae; Bird handler -> Chlamydia psittaci; Livestock worker -> Coxiella burnetii.
The correct pairings align each distinct clinical syndrome and epidemiological exposure with its classic respiratory pathogen. Identifying these unique risk factors—such as avian exposure for psittacosis, contaminated water aerosols for Legionnaires' disease, and livestock exposure for Q fever—is crucial because these organisms dictate specific antimicrobial management that differs from typical community-acquired pneumonia pathways.

Step-by-Step Solution

1
Identify the unique epidemiological risk factor in each patient's history.
Identified exposures: alcohol dependence (aspiration risk), cooling tower (aerosolized water), dormitory (close quarters), bird handling (avian zoonosis), and livestock farm (ruminant zoonosis).
Epidemiological exposures are the primary diagnostic clues for differentiating atypical and specific bacterial pneumonias.
2
Correlate the distinct systemic clinical findings with known pathogen profiles.
Linked thick hemoptysis to lobar necrosis, hyponatremia/diarrhea to systemic infection, targetoid rash to erythema multiforme, and hepatitis without rash to specific zoonoses.
Many of these pathogens present with classic extrapulmonary manifestations that confirm the diagnosis alongside the pulmonary findings.
3
Pair each synthesized clinical and epidemiological profile with the correct pathogen.
The final pairings correctly align the historical and clinical clues to Klebsiella, Legionella, Mycoplasma, C. psittaci, and C. burnetii.
Accurate pathogen identification guides the selection of targeted antimicrobial therapy, such as adding a macrolide or fluoroquinolone for atypical coverage.

Key Concept

Clinical and epidemiological differentiation of atypical and specific lobar pneumonias to guide targeted antimicrobial therapy.
Estimated Time:1m 30s
Question 45Question →

During morning rounds in the intensive care unit, the medical team evaluates a patient recovering from a catheter-associated bloodstream infection. Empiric therapy with intravenous vancomycin and cefepime was initiated three days ago for suspected sepsis. The patient is currently afebrile and hemodynamically stable, and the offending central venous catheter has been removed. Final blood culture results from admission now reveal growth of *Enterococcus faecalis* in two out of two sets. The isolate demonstrates susceptibility to ampicillin, vancomycin, linezolid, and daptomycin. Which of the following is the most appropriate modification to this patient's antimicrobial regimen?

Show answer & explanation

Answer: Discontinue vancomycin and cefepime, and initiate intravenous ampicillin

Answer

Discontinue vancomycin and cefepime, and initiate intravenous ampicillin
The correct approach is to discontinue the broad-spectrum empiric regimen and initiate intravenous ampicillin. For *Enterococcus faecalis* infections that are susceptible to ampicillin, beta-lactam therapy (such as ampicillin or penicillin) is the treatment of choice. Ampicillin is preferred over vancomycin because it is highly active, bactericidal, has a narrower spectrum of activity, and helps prevent the development of vancomycin-resistant enterococci (VRE). De-escalating therapy once culture and susceptibility data are available is a core principle of antibiotic stewardship.

Step-by-Step Solution

1
Identify the pathogen and its susceptibility profile from the blood culture results.
The pathogen is *Enterococcus faecalis*, which is susceptible to ampicillin, vancomycin, linezolid, and daptomycin.
Correct identification and susceptibility testing are required to transition from empiric to targeted therapy.
2
Determine the optimal targeted therapy for susceptible *Enterococcus*.
Ampicillin is the drug of choice for susceptible *Enterococcus faecalis* due to its bactericidal activity and narrow spectrum.
Beta-lactams are preferred over vancomycin for susceptible isolates to ensure optimal efficacy and minimize resistance.
3
Apply principles of antimicrobial stewardship to the current regimen.
The overly broad empiric agents (vancomycin and cefepime) should be discontinued, and targeted therapy with intravenous ampicillin should be initiated.
De-escalating therapy reduces the risk of adverse effects, lowers costs, and prevents the emergence of multidrug-resistant organisms.

Key Concept

Antimicrobial Stewardship and Enterococcal Bacteremia Management
Question 46Question →

A 6868-year-old man is hospitalized due to a 44-week history of fatigue, intermittent fevers, and unintentional weight loss. Two months ago, he underwent a cystoscopy for evaluation of hematuria. His temperature is 38.2∘C38.2^\circ\text{C} (100.8∘F100.8^\circ\text{F}), pulse is 92/min92/\text{min}, and blood pressure is 118/74 mm Hg118/74\text{ mm Hg}. Physical examination reveals small, linear, dark red streaks in the nail beds of both hands and a new grade 3/63/6 holosystolic murmur heard best at the cardiac apex.

Echocardiography demonstrates a 1.2-cm1.2\text{-cm} mobile vegetation on the mitral valve with moderate mitral regurgitation.

Laboratory studies show:
Leukocyte count: 14,500/mm314,500/\text{mm}^3
Serum creatinine: 2.2 mg/dL2.2\text{ mg/dL} (baseline: 1.0 mg/dL1.0\text{ mg/dL})

Three sets of blood cultures are drawn, and the patient is started empirically on intravenous vancomycin and piperacillin-tazobactam. Forty-eight hours later, all blood culture bottles grow *Enterococcus faecalis*. Susceptibility testing reveals:

Ampicillin: Susceptible
Vancomycin: Susceptible
Piperacillin-tazobactam: Susceptible
Gentamicin: High-level resistance

Which of the following is the most appropriate targeted pharmacotherapy for this patient?

Show answer & explanation

Answer: Intravenous ampicillin and intravenous ceftriaxone

Answer

Intravenous ampicillin and intravenous ceftriaxone
The correct targeted therapy is the combination of intravenous ampicillin and intravenous ceftriaxone. This patient has *Enterococcus faecalis* native valve infective endocarditis following a genitourinary procedure. Enterococci are intrinsically tolerant to many antibiotics; therefore, endocarditis treatment requires a synergistic, bactericidal regimen. While ampicillin plus an aminoglycoside (like gentamicin) is a traditional regimen, this patient's isolate demonstrates high-level gentamicin resistance (HLGR), which abolishes the synergistic effect. Additionally, the patient has acute kidney injury, making nephrotoxic agents contraindicated. The combination of ampicillin and ceftriaxone provides excellent bactericidal synergy through complementary binding of different penicillin-binding proteins (PBPs), effectively bypassing the need for aminoglycosides, and is the standard of care for HLGR *E. faecalis* endocarditis.

Step-by-Step Solution

1
Diagnose the primary condition based on clinical and echocardiographic findings.
The patient has native valve infective endocarditis (IE), evidenced by fever, splinter hemorrhages, a new mitral murmur, and a valvular vegetation on echocardiography.
Identifying the deep-seated nature of the infection is crucial, as IE requires prolonged, bactericidal therapy rather than bacteriostatic drugs.
2
Identify the pathogen and interpret the susceptibility profile.
The causative organism is Enterococcus faecalis. The susceptibility panel shows it is sensitive to ampicillin but has high-level gentamicin resistance (HLGR).
E. faecalis typically requires synergistic therapy for endocarditis. HLGR indicates that adding an aminoglycoside will not produce the required bactericidal synergy.
3
Select the optimal targeted antibiotic regimen considering patient comorbidities.
Intravenous ampicillin plus intravenous ceftriaxone is selected.
This combination provides dual beta-lactam synergy, which is bactericidal and highly effective against HLGR strains. It also avoids the nephrotoxicity of aminoglycosides, which is essential given the patient's acute kidney injury (creatinine 2.2 mg/dL).

Key Concept

Treatment of Enterococcus faecalis infective endocarditis requires bactericidal synergy. For isolates with high-level aminoglycoside resistance or in patients with renal impairment, the combination of ampicillin and ceftriaxone is the first-line targeted therapy.
Question 47Question →

A 52-year-old woman is hospitalized for induction chemotherapy for acute myeloid leukemia. On hospital day 12, she develops a new-onset fever of 38.7∘C38.7^\circ\text{C} (101.7∘F101.7^\circ\text{F}). Her blood pressure is 118/74 mm Hg, pulse is 98/min, and respirations are 16/min. Physical examination reveals no focal source of infection, and the exit site of her right internal jugular central venous catheter is clean without erythema or induration. Laboratory studies show an absolute neutrophil count of 150/mm3150/\text{mm}^3. She is hemodynamically stable and appears fatigued.

Arrange the following steps in the most appropriate chronological sequence for the management of this patient's neutropenic fever.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence for managing high-risk neutropenic fever is: 1) Obtain blood cultures (central and peripheral), 2) Initiate empiric antipseudomonal beta-lactam therapy, 3) Reassess clinical response at 48-72 hours without prematurely changing antibiotics, and 4) Add empiric antifungal therapy if fever persists after 4-7 days.
The standard sequence for managing high-risk febrile neutropenia begins with obtaining appropriate diagnostic cultures (blood, urine, sputum if indicated) before giving antibiotics. This is immediately followed by broad-spectrum antipseudomonal monotherapy. Because time to defervescence can be up to a week, the patient is observed for 48-72 hours before considering any changes to the antibacterial regimen, provided they remain hemodynamically stable. Finally, if the fever persists beyond 4 to 7 days of broad-spectrum antibacterial coverage, empiric antifungal therapy is added to cover unrecognized fungal pathogens.

Step-by-Step Solution

1
Analyze the patient's clinical presentation.
The patient has high-risk febrile neutropenia (ANC < 500/mm3500/\text{mm}^3, fever > 38.3∘C38.3^\circ\text{C}) without hemodynamic instability or catheter-site infection.
This determines the urgency and scope of the required empiric antimicrobial coverage.
2
Determine the immediate initial intervention.
Blood cultures must be drawn from both the central line and a peripheral vein before administering any antibiotics.
Administering antibiotics prior to drawing cultures rapidly sterilizes the blood, preventing the identification of the pathogen and hindering later targeted therapy.
3
Select the appropriate initial empiric antibiotic.
Monotherapy with an antipseudomonal beta-lactam (e.g., cefepime, meropenem, or piperacillin-tazobactam) is indicated.
Broad-spectrum coverage including Pseudomonas is universally required. MRSA coverage (vancomycin) is withheld initially because there is no hypotension, pneumonia, or catheter-site erythema.
4
Determine the short-term follow-up strategy.
Maintain the current regimen and reassess the patient at 48 to 72 hours.
Prematurely altering antibiotics before allowing time for clinical response or culture results promotes antibiotic resistance and increases the risk of medication toxicity.
5
Identify the threshold for adding antifungal coverage.
Add an echinocandin or mold-active azole only if the fever persists beyond 4 to 7 days.
Prolonged neutropenic fever despite broad-spectrum antibacterials carries a high probability of occult invasive fungal infection (e.g., Candida, Aspergillus).

Key Concept

Management algorithm for high-risk neutropenic fever.

Alternative Method

While monotherapy with an antipseudomonal beta-lactam is standard, patients presenting with hemodynamic instability or septic shock should receive dual antipseudomonal coverage (e.g., beta-lactam plus an aminoglycoside) and immediate MRSA coverage (vancomycin) as their initial step.
Estimated Time:1m 30s
Question 48Question →

A 64-year-old female patient is currently hospitalized for the treatment of acute pyelonephritis. She initially presented to the emergency department three days ago with severe right-sided flank pain, dysuria, and a temperature of 39.2∘C39.2^\circ\text{C} (102.6∘F102.6^\circ\text{F}). Blood cultures were drawn, and empiric intravenous ceftriaxone was initiated. The admission blood cultures show no growth to date. However, the urine culture obtained prior to antibiotic administration has grown >105>10^5 colony-forming units/mL of *Escherichia coli*. The susceptibility report is as follows:

Antimicrobial AgentResult
AmoxicillinResistant
CefazolinResistant
CeftriaxoneResistant
CefepimeResistant
CiprofloxacinResistant
ErtapenemSusceptible
MeropenemSusceptible
NitrofurantoinSusceptible
Trimethoprim-sulfamethoxazoleSusceptible

Today, the patient reports that her flank pain has nearly resolved. Her current temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure is 122/78 mmHg122/78 \text{ mmHg}, and heart rate is 78/min78/\text{min}. She is tolerating a regular diet without nausea.

Based on the culture results and the patient's clinical progress, which of the following is the most appropriate next step in the pharmacologic management of this patient?

Show answer & explanation

Answer: Transition to oral trimethoprim-sulfamethoxazole

Answer

Transition to oral trimethoprim-sulfamethoxazole
The correct response identifies that this patient has acute pyelonephritis caused by an Extended-Spectrum Beta-Lactamase (ESBL)-producing strain of E. coli, evidenced by resistance to ceftriaxone and cefepime. Because the patient is now afebrile, hemodynamically stable, and able to tolerate an oral diet, she is an excellent candidate for step-down therapy from intravenous to oral antibiotics. This transition minimizes hospital length of stay and reduces the risks associated with intravenous catheters. Trimethoprim-sulfamethoxazole is the optimal choice; the isolate is highly susceptible, and the medication achieves excellent concentrations in both the urine and the renal parenchyma.

Step-by-Step Solution

1
Interpret the antibiotic susceptibility profile.
The E. coli isolate is resistant to third- and fourth-generation cephalosporins, indicating it is an Extended-Spectrum Beta-Lactamase (ESBL) producer.
Accurate identification of the resistance mechanism dictates which antibiotic classes can be safely used.
2
Assess the patient's current clinical stability.
The patient is afebrile, hemodynamically stable, and tolerating an oral diet.
Clinical stability determines whether the patient must remain on intravenous therapy or can be transitioned to an oral regimen.
3
Select the appropriate targeted oral agent based on pharmacokinetics.
Trimethoprim-sulfamethoxazole is selected because it is susceptible and penetrates renal tissue, whereas nitrofurantoin does not.
Pyelonephritis requires antibiotics that achieve high tissue concentrations in the kidneys, not just the lower urinary tract.

Key Concept

Management of acute pyelonephritis caused by Extended-Spectrum Beta-Lactamase (ESBL)-producing Enterobacteriaceae involves transitioning clinically stable patients to highly bioavailable oral antibiotics with adequate renal tissue penetration, such as trimethoprim-sulfamethoxazole, to promote antibiotic stewardship and avoid unnecessary intravenous carbapenem use.
Estimated Time:1m 30s
Question 49Question →

Match each clinical infectious disease vignette with its most appropriate targeted pharmacotherapy or first-line treatment regimen.

Click a left item, then click its matching right item

Items

A 45-year-old man with poor dentition presents with a chronic, indurated submandibular mass and multiple sinus tracts exuding yellowish purulent discharge. Microscopy of the exudate shows branching, non-acid-fast, Gram-positive bacilli.
A 58-year-old renal transplant recipient presents with fever, focal seizures, and a cavitary lung lesion. Sputum microscopy demonstrates filamentous, branching, Gram-positive rods that are weakly acid-fast.
A 65-year-old man with acute myeloid leukemia develops profound neutropenia and persistent fever despite broad-spectrum antibacterials. Chest CT reveals a dense pulmonary macronodule surrounded by a ground-glass halo.
A 32-year-old man with advanced HIV presents with a 2-week history of insidious headache and lethargy. Cerebrospinal fluid analysis reveals elevated opening pressure and encapsulated yeast organisms on an India ink preparation.
A 72-year-old woman is evaluated for acute-onset altered mental status and fever. Cerebrospinal fluid analysis shows neutrophilic pleocytosis. Gram stain reveals intracellular and extracellular Gram-positive bacilli with tumbling motility.

Matches

Show answer & explanation

Answer

Vignette 1 matches with Penicillin G/Amoxicillin, Vignette 2 matches with Trimethoprim-sulfamethoxazole, Vignette 3 matches with Voriconazole, Vignette 4 matches with Amphotericin B and flucytosine, and Vignette 5 matches with Ampicillin.
Each specific pathogen presentation is correctly matched with its guideline-directed targeted antimicrobial therapy based on strict microbiological characteristics (Gram stain, acid-fastness, India ink) and classic clinical syndromes.

Step-by-Step Solution

1
Analyze the first vignette for key diagnostic microbiological and clinical features.
Identified cervicofacial mass with sinus tracts and branching non-acid-fast bacilli as an Actinomyces infection.
To determine the underlying pathogen and recall its specific targeted treatment (Penicillin).
2
Analyze the second vignette for key diagnostic microbiological and clinical features.
Identified pulmonary and CNS involvement in a transplant patient with weakly acid-fast branching bacilli as a Nocardia infection.
To differentiate from Actinomyces and select the correct antimicrobial therapy (TMP-SMX).
3
Analyze the third vignette for key radiologic and host-factor features.
Identified neutropenic fever with a chest CT 'halo sign' as invasive pulmonary aspergillosis.
To recognize this severe opportunistic fungal pneumonia which necessitates Voriconazole therapy.
4
Analyze the fourth vignette for key neurologic and fluid-analysis features.
Identified subacute meningitis in an immunocompromised patient with encapsulated yeast as a Cryptococcal infection.
To select the appropriate synergistic induction regimen of Amphotericin B and flucytosine.
5
Analyze the fifth vignette for key demographic and microscopic features.
Identified meningitis in an elderly patient with Gram-positive motile bacilli as Listeria monocytogenes.
To recall that Listeria possesses intrinsic resistance to standard empiric cephalosporins, requiring the addition of Ampicillin.

Key Concept

Diagnosis and targeted pharmacotherapy of specific opportunistic and severe infectious diseases
Question 50Question →

For each of the following hospitalized patients presenting with severe, confirmed, or highly suspected infections, select the most appropriate definitive or targeted empiric intravenous antimicrobial therapy from the options provided.

Click a left item, then click its matching right item

Items

A 62-year-old patient developing ventilator-associated pneumonia; endotracheal aspirate culture grows extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae.
A 54-year-old patient with a central line-associated bloodstream infection; blood cultures isolate vancomycin-resistant Enterococcus faecium.
A 71-year-old patient with complicated pyelonephritis; urine and blood cultures grow Enterobacter cloacae demonstrating inducible AmpC beta-lactamase production.
A 48-year-old critically ill patient in the intensive care unit who develops new-onset septic shock and candidemia; fungal species identification is pending.

Matches

Show answer & explanation

Answer

The correct pairings match specific resistance mechanisms and pathogen profiles with their definitive antimicrobial therapy: ESBL Klebsiella with meropenem, VRE with daptomycin, AmpC Enterobacter with cefepime, and critically ill candidemia with micafungin.
Each clinical scenario requires a highly specific antimicrobial agent based on pathogen characteristics. Carbapenems (meropenem) are required for ESBL-producing organisms because they resist hydrolysis by these specific enzymes. Daptomycin is utilized for VRE because enterococci have inherent cephalosporin resistance, and VRE's altered peptidoglycan precursors render vancomycin ineffective. Cefepime avoids the induction of AmpC beta-lactamases seen in 'SPACE' organisms (like Enterobacter). Finally, echinocandins (micafungin) are the standard of care for empiric candidemia in the critically ill due to the high mortality associated with missing fluconazole-resistant strains.

Step-by-Step Solution

1
Analyze the pathogen and its specific resistance mechanism described in each clinical vignette.
Identified ESBL-producing Klebsiella, VRE, AmpC-producing Enterobacter, and empiric candidemia in a critically ill patient.
Accurate pathogen identification is required to select structurally stable and mechanism-appropriate antimicrobials.
2
Match the identified resistance mechanisms to the antimicrobial class capable of overcoming them.
ESBL requires carbapenems; VRE requires membrane depolarizers (daptomycin) or oxazolidinones (linezolid); AmpC requires 4th-generation cephalosporins (cefepime) or carbapenems; severe undifferentiated candidemia requires echinocandins.
Beta-lactamases hydrolyze specific antibiotic rings; matching ensures the chosen drug will not be deactivated and provides adequate bactericidal or fungicidal activity.

Key Concept

Selection of targeted antimicrobial therapy must account for specific molecular resistance mechanisms (e.g., ESBL, AmpC, VRE) and patient acuity (e.g., risk of azole-resistant Candida in the intensive care unit).
Question 51Question →

Match each patient's clinical presentation with the most appropriate targeted antimicrobial therapy.

Click a left item, then click its matching right item

Items

A 28-year-old pregnant woman (10 weeks gestation) who developed a painless, 8-cm erythematous rash with central clearing on her right thigh, one week after a hiking trip in Connecticut.
A 6-year-old boy who presents with a 3-day history of high fever, severe headache, and a petechial rash that began on his wrists and ankles before spreading centrally, following a camping trip in North Carolina.
A 45-year-old man with a history of splenectomy who presents with fever, jaundice, dark urine, and a peripheral blood smear demonstrating intraerythrocytic pleomorphic ring forms and tetrads.
A 55-year-old man who presents with fever, a painful ulcer on his right index finger, and tender right axillary lymphadenopathy, 5 days after skinning wild rabbits on a hunting trip.

Matches

Show answer & explanation

Answer

The correct pairings are: 1) Pregnant woman with Lyme disease matches with Oral amoxicillin; 2) 6-year-old boy with RMSF matches with Oral doxycycline; 3) Asplenic man with Babesiosis matches with Oral atovaquone and azithromycin; 4) Man with Tularemia matches with Intramuscular streptomycin.
Each clinical vignette provides classic epidemiological and clinical clues for a specific zoonotic or tick-borne infection, testing the ability to select the gold-standard therapy while navigating crucial exceptions, such as pregnancy and pediatric age restrictions.

Step-by-Step Solution

1
Analyze the first clinical scenario involving the pregnant woman with a targetoid rash.
The diagnosis is early localized Lyme disease. The patient is in her first trimester of pregnancy, requiring a teratogen-sparing regimen.
To determine the appropriate antibiotic that is safe for fetal development, leading to the selection of amoxicillin over doxycycline.
2
Analyze the second clinical scenario involving the 6-year-old boy with a centripetally spreading petechial rash.
The diagnosis is Rocky Mountain Spotted Fever. Despite his young age, doxycycline is the standard of care.
To apply the specific clinical exception where doxycycline is used in children under 8 years old because the disease carries a high mortality rate if untreated.
3
Analyze the third clinical scenario involving the asplenic man with hemolytic anemia and tetrads on blood smear.
The diagnosis is babesiosis. First-line therapy consists of anti-parasitic agents, specifically atovaquone combined with azithromycin.
To identify the specific anti-protozoal regimen required for this tick-borne illness.
4
Analyze the fourth clinical scenario involving the man with a finger ulcer and regional lymphadenopathy after rabbit exposure.
The diagnosis is ulceroglandular tularemia. Aminoglycosides are the treatment of choice.
To match the zoonotic pathogen (Francisella tularensis) to its highly effective specific pharmacotherapy.

Key Concept

Selection of targeted antimicrobial therapy for zoonotic and tick-borne infections often requires deviating from general rules based on specific patient demographics (e.g., pregnancy, young age) and precise pathogen identification.

Alternative Method

For severe, life-threatening babesiosis (e.g., parasitemia greater than 10%, severe hemolysis, or pulmonary edema), an alternative regimen of intravenous clindamycin and oral quinine is utilized, and patients may additionally require red blood cell exchange transfusion.
Estimated Time:2m 0s
Question 52Question →

During morning rounds, a 52-year-old woman reports feeling chilled and fatigued. She is currently hospitalized on day 10 of induction chemotherapy for acute promyelocytic leukemia. Her temperature is 38.7∘C38.7^\circ\text{C} (101.7∘F101.7^\circ\text{F}), blood pressure is 122/76122/76 mmHg, heart rate is 9494/min, and respiratory rate is 1616/min. Pulse oximetry shows 98%98\% on room air. Physical examination reveals a right subclavian central venous port with a clean, dry, and intact dressing; there is no erythema, fluctuance, or tenderness around the site. The remainder of the examination, including thorough skin and mucosal evaluation, is unremarkable. Laboratory studies show a leukocyte count of 600/mm3600/\text{mm}^3 and an absolute neutrophil count of 120/mm3120/\text{mm}^3. Blood cultures are drawn from the central port and a peripheral vein. Which of the following is the most appropriate next step in pharmacotherapy?

Show answer & explanation

Answer: Intravenous cefepime

Answer

Intravenous cefepime
The correct answer is intravenous cefepime. This patient has febrile neutropenia (temperature ≥38.3∘C\ge 38.3^\circ\text{C} and absolute neutrophil count <500/mm3< 500/\text{mm}^3), which is a life-threatening medical emergency. Because she is a high-risk patient (inpatient at the time of fever onset, undergoing intensive induction chemotherapy), she requires immediate empiric intravenous antibiotics. The initial regimen must have potent bactericidal activity against Pseudomonas aeruginosa and other serious Gram-negative pathogens. Monotherapy with an antipseudomonal beta-lactam (such as cefepime, meropenem, or piperacillin-tazobactam) is the standard of care. There are no specific indications to add Gram-positive or fungal coverage at this initial stage.

Step-by-Step Solution

1
Identify the clinical syndrome from the patient's presentation and laboratory results.
The patient has febrile neutropenia, defined as a single oral temperature of ≥38.3∘C\ge 38.3^\circ\text{C} (101.0∘F101.0^\circ\text{F}) and an absolute neutrophil count <500/mm3< 500/\text{mm}^3.
Recognizing febrile neutropenia is critical as it is a medical emergency requiring prompt empiric antibiotics.
2
Stratify the patient's risk to determine the setting and route of therapy.
The patient is classified as high-risk because she is an inpatient undergoing induction chemotherapy with anticipated prolonged and profound neutropenia.
High-risk patients require admission (if not already hospitalized) and intravenous broad-spectrum antibiotics.
3
Evaluate the patient for specific indications that require targeted coverage beyond standard Gram-negative therapy.
The patient is hemodynamically stable, has a clean central venous port site, and has no signs of severe skin infection or pneumonia.
This confirms that additional Gram-positive coverage (like vancomycin) is not initially indicated.
4
Select the most appropriate empiric antimicrobial regimen.
Intravenous monotherapy with an antipseudomonal beta-lactam, such as cefepime, is the correct choice.
It provides necessary bactericidal activity against Pseudomonas aeruginosa and other serious pathogens without promoting unnecessary resistance.

Key Concept

High-risk febrile neutropenia is a medical emergency requiring immediate empiric intravenous monotherapy with an antipseudomonal beta-lactam (e.g., cefepime, meropenem, piperacillin-tazobactam); vancomycin is only added for specific clinical indications.
Question 53Question →

A 54-year-old man with a history of end-stage renal disease on hemodialysis is currently hospitalized for management of suspected endocarditis. He presented three days ago with a two-week history of fatigue, severe night sweats, and intermittent fevers. His hemodialysis is accessed via a right internal jugular tunneled catheter. Vital signs today show a temperature of 39.4∘C39.4^\circ\text{C} (102.9∘F102.9^\circ\text{F}), blood pressure of 108/64 mm Hg108/64\text{ mm Hg}, pulse of 115/min115/\text{min}, and respiratory rate of 16/min16/\text{min}. Cardiac auscultation reveals a new high-pitched, blowing early diastolic murmur heard best at the left sternal border. Transesophageal echocardiography reveals a 1.5-cm1.5\text{-cm} oscillating vegetation on the aortic valve with severe aortic regurgitation. At the time of admission, empiric intravenous vancomycin and cefepime were initiated. Blood cultures drawn before the first antibiotic dose are now growing *Staphylococcus aureus*. The isolate is sensitive to oxacillin, cefazolin, and vancomycin, but resistant to penicillin. Which of the following is the most appropriate next step in the pharmacologic management of this patient?

Show answer & explanation

Answer: Discontinue vancomycin and cefepime, and begin intravenous cefazolin

Answer

Discontinue vancomycin and cefepime, and begin intravenous cefazolin
For methicillin-susceptible Staphylococcus aureus (MSSA) infective endocarditis, anti-staphylococcal beta-lactams (such as cefazolin, nafcillin, or oxacillin) are the treatment of choice. They have been shown to be more rapidly bactericidal and are associated with significantly lower rates of treatment failure and mortality compared to vancomycin. Therefore, the empiric regimen should be de-escalated to a targeted, narrow-spectrum beta-lactam agent once susceptibility results confirm the presence of MSSA.

Step-by-Step Solution

1
Identify the primary diagnosis based on clinical and diagnostic findings.
The patient has native valve infective endocarditis, complicated by severe aortic regurgitation.
Establishes the severity of the infection and dictates the need for aggressive, bactericidal intravenous therapy.
2
Analyze the microbiological culture and susceptibility data.
Blood cultures are growing methicillin-susceptible Staphylococcus aureus (MSSA).
Guides the transition from empiric therapy to targeted antimicrobial therapy.
3
Select the optimal pharmacotherapy for the identified pathogen.
Intravenous cefazolin (or another anti-staphylococcal beta-lactam like nafcillin) is selected.
Anti-staphylococcal beta-lactams are superior to vancomycin for MSSA infections, providing better clinical outcomes and faster bacterial clearance.

Key Concept

For methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia and infective endocarditis, anti-staphylococcal beta-lactams (e.g., cefazolin, nafcillin) are the treatment of choice and are superior to vancomycin.
Question 54Question →

A 6464-year-old man is admitted to the hospital with a 22-week history of progressively worsening mid-back pain and low-grade fevers. He has a history of poorly controlled type 2 diabetes mellitus. His temperature is 38.2∘C38.2^\circ\text{C} (100.8∘F100.8^\circ\text{F}), blood pressure is 128/78 mmHg128/78\text{ mmHg}, and pulse is 92/min92\text{/min}. Physical examination reveals point tenderness over the T10−T11T10-T11 spinous processes. Neurologic examination of the lower extremities is completely normal. Laboratory studies show an erythrocyte sedimentation rate (ESR) of 85 mm/h85\text{ mm/h} and a C-reactive protein (CRP) level of 112 mg/L112\text{ mg/L}. Magnetic resonance imaging (MRI) of the thoracic spine demonstrates abnormal marrow signal and enhancement of the T10T10 and T11T11 vertebral bodies with a small adjacent fluid collection, diagnostic of vertebral osteomyelitis. Two sets of blood cultures are obtained, and the patient is started on empiric intravenous vancomycin and piperacillin-tazobactam. On hospital day 33, the patient's temperature is 37.4∘C37.4^\circ\text{C} (99.3∘F99.3^\circ\text{F}). Both sets of blood cultures are positive for Staphylococcus aureus that is susceptible to oxacillin, cefazolin, and vancomycin, but resistant to penicillin. Which of the following is the most appropriate next step in the pharmacologic management of this patient?

Show answer & explanation

Answer: Discontinue both current antibiotics and initiate intravenous cefazolin

Answer

Discontinue both current antibiotics and initiate intravenous cefazolin.
The most appropriate next step is to transition the patient to an intravenous anti-staphylococcal beta-lactam such as cefazolin. The patient has vertebral osteomyelitis and bacteremia caused by methicillin-susceptible Staphylococcus aureus (MSSA). Once culture susceptibilities confirm MSSA, antimicrobial stewardship principles dictate de-escalating from broad-spectrum empiric therapy to definitive, targeted therapy. For severe, deep-seated MSSA infections, beta-lactam antibiotics (e.g., cefazolin, nafcillin, oxacillin) are the standard of care because they demonstrate superior bactericidal activity, faster clearance of bacteremia, and lower mortality rates when compared to vancomycin.

Step-by-Step Solution

1
Analyze the culture and susceptibility data.
Blood cultures grew Staphylococcus aureus that is susceptible to oxacillin and cefazolin, definitively identifying the pathogen as methicillin-susceptible Staphylococcus aureus (MSSA).
Identifying the specific pathogen and its resistance profile is mandatory before adjusting empiric antibiotic therapy.
2
Apply principles of antimicrobial stewardship.
The broad-spectrum empiric regimen (vancomycin and piperacillin-tazobactam) must be de-escalated to a narrow-spectrum agent targeted at MSSA.
De-escalation minimizes drug toxicity, reduces collateral damage to the microbiome, and prevents the emergence of multidrug-resistant organisms.
3
Select the optimal definitive therapy for MSSA osteomyelitis.
Intravenous cefazolin (or nafcillin/oxacillin) is selected over vancomycin.
Anti-staphylococcal beta-lactams have superior bactericidal activity against MSSA compared to vancomycin, resulting in better clinical outcomes and faster bacterial clearance.

Key Concept

Antimicrobial Stewardship and MSSA Treatment
Question 55Question →

Match each HIV-positive patient's clinical presentation and neuroimaging or cerebrospinal fluid (CSF) finding with the most likely causative pathogen or etiology.

Click a left item, then click its matching right item

Items

A 35-year-old with a CD4 count of 45 cells/μL45 \text{ cells}/\mu\text{L} presents with new-onset seizures. Brain MRI shows multiple ring-enhancing lesions primarily in the basal ganglia with surrounding edema.
A 42-year-old with a CD4 count of 30 cells/μL30 \text{ cells}/\mu\text{L} presents with progressive hemiparesis and speech difficulty. Brain MRI reveals asymmetric, non-enhancing white matter lesions without mass effect.
A 38-year-old with a CD4 count of 80 cells/μL80 \text{ cells}/\mu\text{L} presents with headache, fever, and neck stiffness. CSF analysis demonstrates an elevated opening pressure and is positive for encapsulated yeast organisms on India ink stain.
A 40-year-old with a CD4 count of 20 cells/μL20 \text{ cells}/\mu\text{L} presents with progressive confusion. Brain MRI shows a solitary, weakly ring-enhancing periventricular mass. CSF polymerase chain reaction is positive for a specific oncogenic virus.

Matches

Show answer & explanation

Answer

The correct matches correlate characteristic neuroradiological and CSF findings with their specific opportunistic etiologies: multiple ring-enhancing lesions match with Toxoplasma gondii, non-enhancing white matter lesions match with JC virus, elevated CSF opening pressure with encapsulated yeast matches with Cryptococcus neoformans, and a solitary periventricular mass with oncogenic viral DNA matches with Epstein-Barr virus.
In advanced HIV, distinct CNS pathogens produce hallmark clinical and radiological phenotypes. Toxoplasma gondii causes multiple ring-enhancing lesions. JC virus targets oligodendrocytes, causing non-enhancing white matter demyelination without mass effect (PML). Cryptococcus neoformans causes meningoencephalitis with characteristically high opening pressure. Epstein-Barr virus drives Primary CNS Lymphoma, typically appearing as a single periventricular mass.

Step-by-Step Solution

1
Analyze the CD4 count and immune status of each patient in the vignettes.
All patients have advanced AIDS (CD4 < 100 cells/µL), putting them at risk for severe central nervous system opportunistic infections.
CD4 counts stratify the risk for specific opportunistic pathogens, helping to narrow the differential diagnosis.
2
Evaluate the MRI and CSF descriptions for classic pathognomonic patterns.
Basal ganglia ring-enhancing lesions point to toxoplasmosis; non-enhancing white matter lesions to progressive multifocal leukoencephalopathy (PML); encapsulated yeast to cryptococcosis; and a solitary periventricular mass to primary CNS lymphoma.
Neuroimaging patterns and basic CSF stains are the primary non-invasive diagnostic differentiators for HIV-associated CNS lesions.

Key Concept

Diagnosis of central nervous system opportunistic infections in HIV/AIDS based on neuroimaging and cerebrospinal fluid analysis.
Estimated Time:1m 30s
Question 56Question →

Match each patient's clinical presentation with the most appropriate initial or definitive targeted pharmacotherapy.

Click a left item, then click its matching right item

Items

A 34-year-old man with a history of renal transplantation presents with fever, pleuritic chest pain, and hemoptysis. Chest CT reveals a dense nodule with a surrounding halo of ground-glass opacity. Serum galactomannan assay is positive.
A 52-year-old woman with diabetic ketoacidosis presents with unilateral facial pain, periorbital edema, and a black necrotic eschar on the nasal turbinate. Biopsy shows broad, nonseptate hyphae branching at wide angles.
A 41-year-old forestry worker from Wisconsin presents with a chronic cough, low-grade fever, and ulcerated, verrucous skin lesions on his arms. Sputum microscopy reveals large yeast cells with broad-based budding.
A 29-year-old man with HIV and a CD4 count of 40 cells/mm³ presents with fever, insidious onset of severe headache, and lethargy. CSF analysis shows elevated opening pressure and a profoundly positive cryptococcal antigen test. He is treatment-naïve.

Matches

Show answer & explanation

Answer

Invasive aspergillosis is treated with Voriconazole. Mucormycosis is treated with Liposomal amphotericin B and surgical debridement. Mild-to-moderate Blastomycosis is treated with Itraconazole. Cryptococcal meningitis is treated with Liposomal amphotericin B and flucytosine.
Each fungal pathogen has a distinct targeted therapy based on its intrinsic susceptibilities, the severity of illness, and the site of infection. Invasive aspergillosis requires voriconazole. Mucormycosis requires a combined medical (liposomal amphotericin B) and surgical approach. Mild-to-moderate blastomycosis responds well to itraconazole. Cryptococcal meningitis induction requires a fungicidal regimen of liposomal amphotericin B and flucytosine to rapidly clear the central nervous system.

Step-by-Step Solution

1
Analyze the first clinical presentation to identify the pathogen and treatment.
The renal transplant patient with hemoptysis, a 'halo sign' on CT, and a positive galactomannan assay has invasive aspergillosis, which is treated with voriconazole.
Voriconazole provides superior survival benefits for invasive Aspergillus infections compared to other systemic antifungals.
2
Evaluate the second vignette for diagnosis and management.
The patient with diabetic ketoacidosis, a nasal eschar, and right-angle branching nonseptate hyphae has mucormycosis. This requires liposomal amphotericin B and urgent surgical debridement.
Medical therapy alone cannot penetrate the necrotic, ischemic tissue characteristic of mucormycosis; surgical removal of the infected tissue is mandatory.
3
Identify the pathogen in the third scenario and its corresponding therapy.
The forestry worker from Wisconsin with chronic cough, verrucous skin lesions, and broad-based budding yeast has mild-to-moderate blastomycosis, correctly treated with oral itraconazole.
Itraconazole is highly effective and the drug of choice for non-life-threatening, non-CNS endemic mycoses.
4
Assess the fourth vignette to determine the appropriate induction therapy.
The HIV patient with advanced immunosuppression, headache, and positive CSF cryptococcal antigen has cryptococcal meningitis. Standard induction therapy is liposomal amphotericin B combined with flucytosine.
This combination rapidly sterilizes the cerebrospinal fluid and significantly reduces mortality during the induction phase (typically the first two weeks).

Key Concept

Targeted Antifungal Pharmacotherapy for Systemic and Opportunistic Mycoses
Question 57Question →

A 28-year-old surgical resident sustains a deep, bleeding puncture wound to her left index finger from a hollow-bore needle immediately after drawing arterial blood. The source patient is known to be HIV-positive with a high viral load and is concurrently infected with hepatitis C. The resident has previously received the complete hepatitis B vaccine series and has a documented positive surface antibody titer. Arrange the following steps in the most appropriate chronological order for managing this healthcare worker's occupational exposure.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: 1) decontaminate the wound with soap and water, 2) report the incident to occupational health, 3) obtain baseline serologies from the resident, 4) initiate an antiretroviral PEP regimen, and 5) schedule longitudinal follow-up testing.
The management of an occupational needle-stick exposure follows a strict chronological protocol to maximize safety and prophylactic efficacy. Immediate local decontamination with soap and water is the critical first action. Once the wound is stabilized, notifying occupational health ensures access to rapid testing and medications. Baseline serologies must then be drawn from the exposed worker to document their pre-exposure status. Subsequently, empiric three-drug antiretroviral PEP is administered, which is most effective when started within 1 to 2 hours of the injury. Finally, a schedule for serial follow-up testing is established to monitor for delayed seroconversion.

Step-by-Step Solution

1
Decontaminate the wound site.
Immediate physical removal of the pathogen.
Reduces the volume of inoculated viral particles, which is the most critical immediate first aid intervention.
2
Report the exposure to occupational health.
Activation of the institutional exposure protocol.
Provides the legal and logistical framework to expedite laboratory testing and pharmacy dispensing of PEP.
3
Draw baseline serologic testing from the resident.
Establishment of the healthcare worker's pre-exposure HIV and HCV status.
Documenting baseline seronegativity is required before initiating therapy to ensure any future seroconversion is accurately attributed to the occupational injury.
4
Initiate empiric three-drug PEP.
Pharmacologic blockade of viral replication.
The efficacy of PEP is highly time-dependent and is optimized when administered within 1 to 2 hours of exposure.
5
Schedule follow-up testing.
Longitudinal monitoring plan established.
Because seroconversion can be delayed for several months, serial testing ensures any failure of prophylaxis is identified promptly.

Key Concept

Management sequence for occupational needle-stick exposure to bloodborne pathogens.
Question 58Question →

Match each clinical presentation of a suspected or confirmed systemic fungal infection with its most appropriate first-line targeted therapy or initial empiric management strategy.

Click a left item, then click its matching right item

Items

A 38-year-old cave explorer from the Ohio River Valley presents with weeks of fever, dry cough, and hepatosplenomegaly. Urine antigen testing is positive for an endemic fungus.
A 31-year-old man with advanced HIV (CD4 count 45 cells/µL) presents with a severe headache. Cerebrospinal fluid analysis reveals an opening pressure of 300 mm H2O and encapsulated yeast.
A 58-year-old man with diabetic ketoacidosis presents with periorbital pain, facial swelling, and a necrotic nasal eschar. Biopsy shows broad, nonseptate hyphae branching at right angles.
A 45-year-old woman with profound neutropenia following chemotherapy develops pleuritic chest pain and hemoptysis. Chest computed tomography reveals a pulmonary nodule surrounded by a ground-glass opacity (halo sign).
A 52-year-old critically ill patient receiving total parenteral nutrition via a central venous catheter develops new-onset fever, hypotension, and peripheral blood cultures positive for yeast.

Matches

Show answer & explanation

Answer

Histoplasmosis is treated with oral itraconazole. Cryptococcal meningitis induction requires intravenous liposomal amphotericin B and flucytosine. Rhinocerebral mucormycosis requires urgent surgical debridement and intravenous liposomal amphotericin B. Invasive aspergillosis is treated with intravenous voriconazole. Candidemia associated with a central line requires an intravenous echinocandin and central venous catheter removal.
Each fungal pathogen has a highly specific first-line therapeutic approach determined by clinical trials and current guidelines. Itraconazole is standard for mild-to-moderate histoplasmosis. Cryptococcal meningitis necessitates dual therapy (amphotericin B + flucytosine) for rapid CSF sterilization. Mucormycosis uniquely requires surgical intervention alongside amphotericin B due to its angioinvasive, necrotic nature. Voriconazole provides optimal outcomes for invasive aspergillosis. Candidemia in critical illness requires line removal and an echinocandin due to rising non-albicans azole resistance.

Step-by-Step Solution

1
Analyze the cave explorer vignette (Histoplasmosis).
Identify the endemic exposure (spelunking, Ohio River Valley) and positive urine antigen as mild-to-moderate histoplasmosis.
Matching to the appropriate antifungal step-down or outpatient therapy, which is oral itraconazole.
2
Analyze the advanced HIV vignette (Cryptococcosis).
Identify the encapsulated yeast in cerebrospinal fluid with high opening pressure as Cryptococcal meningitis.
Requires aggressive fungicidal induction therapy capable of penetrating the central nervous system, specifically liposomal amphotericin B and flucytosine.
3
Analyze the diabetic ketoacidosis vignette (Mucormycosis).
Correlate the necrotic eschar and broad, nonseptate right-angle branching hyphae with rhinocerebral mucormycosis.
Antimicrobial therapy alone is insufficient; matching requires acknowledging the necessity of urgent surgical debridement combined with liposomal amphotericin B.
4
Analyze the neutropenic host vignette (Aspergillosis).
Recognize the classic 'halo sign' and hemoptysis in a severely neutropenic patient as invasive pulmonary aspergillosis.
Voriconazole is superior to amphotericin B for the targeted treatment of invasive Aspergillus infections.
5
Analyze the critically ill patient vignette (Candidemia).
Identify bloodstream yeast in the setting of total parenteral nutrition and a central line as candidemia.
Demands source control via catheter removal and an echinocandin to cover fluconazole-resistant species like Candida glabrata and Candida krusei.

Key Concept

Selecting the correct targeted antifungal therapy or management strategy based on specific clinical presentations, host immune status, and fungal morphologic characteristics.
Estimated Time:1m 30s
Question 59Question →

A 74-year-old man residing in a skilled nursing facility is evaluated on hospital day 33 for a complicated urinary tract infection. He was initially brought to the emergency department for altered mental status and a new fever. On admission, his temperature was 38.9∘C38.9^\circ\text{C} (102.0∘F102.0^\circ\text{F}), and his long-term indwelling urinary catheter was found to be obstructed with purulent sediment. The catheter was promptly removed, and he was started empirically on intravenous vancomycin and piperacillin-tazobactam. Today, the patient is afebrile, his mental status has returned to baseline, and he is tolerating an oral diet. Blood cultures obtained on admission show no growth. A urine culture obtained via straight catheterization prior to antibiotic initiation grows >100,000 CFU/mL>100,000\text{ CFU/mL} of Escherichia coli. Susceptibility testing reveals the organism is susceptible to ceftriaxone, ciprofloxacin, and trimethoprim-sulfamethoxazole, but resistant to ampicillin. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Discontinue vancomycin and piperacillin-tazobactam, and begin oral trimethoprim-sulfamethoxazole.

Answer

Discontinue vancomycin and piperacillin-tazobactam, and begin oral trimethoprim-sulfamethoxazole.
The correct action demonstrates the core principles of antimicrobial stewardship: narrowing the antibiotic spectrum based on culture data and transitioning from intravenous to oral therapy when clinically appropriate. The patient presented with a complicated, catheter-associated urinary tract infection accompanied by systemic symptoms, necessitating empiric broad-spectrum coverage (vancomycin and piperacillin-tazobactam). Now, with source control achieved (catheter removal) and clinical stability established (afebrile, tolerating oral intake), the empiric regimen must be adjusted. The culture shows E. coli susceptible to trimethoprim-sulfamethoxazole, a highly bioavailable oral agent with excellent penetration into the urinary tract and renal parenchyma. Discontinuing the broad intravenous agents and starting oral trimethoprim-sulfamethoxazole provides optimal targeted therapy.

Step-by-Step Solution

1
Evaluate the patient's clinical response to initial empiric therapy.
The patient is clinically stable, afebrile, has returned to his baseline mental status, and is tolerating oral intake.
Determines if the patient has achieved source control and is physiologically eligible for transition from intravenous to oral antibiotics.
2
Analyze the microbiological data and susceptibility results.
Urine culture confirms a single pathogen, Escherichia coli, which is susceptible to trimethoprim-sulfamethoxazole, ceftriaxone, and ciprofloxacin.
Identifies the specific pathogen to allow for de-escalation from empiric broad-spectrum therapy to targeted, narrow-spectrum therapy.
3
Select the most appropriate targeted therapy for a complicated urinary tract infection.
Oral trimethoprim-sulfamethoxazole is chosen.
It provides excellent systemic and renal tissue penetration (unlike nitrofurantoin), strictly targets the isolated pathogen without overly broad coverage, and utilizes the oral route.

Key Concept

Antibiotic de-escalation involves transitioning clinically stable patients from broad-spectrum intravenous empiric antibiotics to narrow-spectrum targeted oral therapy once culture and susceptibility data are available.
Question 60Question →

A 68-year-old man is brought to the emergency department by his family due to confusion, a severe headache, and high fever that began 24 hours ago. He has a history of type 2 diabetes mellitus and hypertension. His temperature is 39.2°C (102.6°F), blood pressure is 112/74 mm Hg, heart rate is 115/min, and respiratory rate is 22/min. Physical examination shows marked nuchal rigidity. Neurologic examination reveals lethargy and a mild left-sided hemiparesis. The physician suspects bacterial meningitis. Arrange the following management steps in the most appropriate chronological order for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of management is: 1) Draw blood for cultures, 2) Administer empiric dexamethasone and broad-spectrum intravenous antibiotics, 3) Obtain a non-contrast CT scan of the head, and 4) Perform a lumbar puncture.
In cases of suspected bacterial meningitis, the general rule is to obtain a lumbar puncture (LP) before initiating empiric antibiotics to maximize the diagnostic yield of cerebrospinal fluid cultures. However, if the patient has 'red flag' indications for a head CT before the LP (such as age > 60, immunocompromise, history of CNS disease, altered mental status, new-onset seizure, or focal neurologic deficits), this standard sequence must be altered. Because obtaining a CT scan delays the LP, empiric antibiotics (and dexamethasone) must be given immediately to prevent poor outcomes from delayed treatment. Blood cultures should always be drawn before giving antibiotics, as this takes only minutes and does not significantly delay therapy. Once cultures are drawn and antibiotics are administered, the patient undergoes the head CT to rule out a mass lesion, followed by the LP if the CT is clear of mass effect.

Step-by-Step Solution

1
Identify the suspected diagnosis and the presence of indications for neuroimaging prior to lumbar puncture.
The patient has suspected bacterial meningitis with indications for a head CT before LP (age > 60, altered mental status, and focal neurologic deficit).
Recognizing these red flags is critical to prevent cerebral herniation from an LP in the setting of increased intracranial pressure.
2
Determine the first step in suspected meningitis when antibiotics are planned.
Blood cultures should be drawn immediately.
Blood cultures take only minutes to obtain and must be collected prior to antibiotic administration to maximize pathogen yield without delaying therapy.
3
Determine the timing of antimicrobial therapy.
Empiric antibiotics and dexamethasone must be administered immediately after blood cultures.
Because the required CT scan and subsequent LP will delay definitive cerebrospinal fluid (CSF) analysis, life-saving empiric therapy must not be delayed.
4
Determine the sequence of the remaining diagnostic procedures.
A head CT is performed, followed by a lumbar puncture if the CT is clear.
The CT rules out mass effect, making the LP safe to perform to obtain CSF for definitive diagnosis.

Key Concept

In patients with suspected bacterial meningitis who have indications for a head CT before lumbar puncture (e.g., age >60, immunocompromise, altered mental status, focal neurologic deficits), blood cultures should be drawn and empiric antibiotics administered immediately, prior to imaging and LP.
PreviousPage 3 / 26Next
Infectious Diseases Practice Questions — USMLE Step 2 CK — Page 3 | Examkin